Long-Term Effects [phpr]
Antihypertensive [phsu]
aliskiren [orch, phsu]
Direct [qlco]
Renin [aapp, enzy]
Inhibitor [qlco]
chronic [tmco]
Haemodialysis [topp]
Patients [podg]
Renin-Angiotensin-Aldosterone System [bdsy]
Suppressed [ftcn]
Renal Disease, End-Stage [dsyn]
Patients [podg]
Dialysis [npop]
inhibitors [chvf]
System [ftcn]
Efficacy [qlco]
Renin inhibitor [phsu]
aliskiren [orch, phsu]
Well [qlco]
Dialysis [npop]
Patients [podg]
Evaluated [ftcn]
Antihypertensive [phsu]
aliskiren [orch, phsu]
Administered [ftcn]
Single [popg]
Daily Dose [qnco]
weeks [tmco]
chronic [tmco]
Haemodialysis [topp]
Patients [podg]
Age-Years [tmco]
Men [popg]
Eight [qnco]
Women [popg]
Blood Pressure [orgf]
Assessed [acty]
Relate [orch]
Blood Pressure [orgf]
reduction [npop]
4 Weeks [tmco]
Average systolic blood pressure [diap]
Dialysis [npop]
Session [evnt]
Reduced [qlco]
lowered [spco]
weeks [tmco]
Pulse Rate [clna]
Altered [ftcn]
serum K+ [lbpr]
Increased [qnco]
weeks [tmco]
Patients [podg]
Systolic blood pressure [clna]
reduction [npop]
Plasma [bdsu]
Renin [aapp, enzy]
immunoreactivity [moft]
Increased [qnco]
Plasma [bdsu]
renin activity [moft]
Angiotensin 2 [aapp, bacs, phsu]
aldosterone levels [lbtr]
Decreased [qnco]
Basal [spco]
Levels [qlco]
Components [mnob]
Renin-Angiotensin-Aldosterone System [bdsy]
Patients [podg]
Systolic blood pressure [clna]
reduction [npop]
N NOS [aapp, imft]
N NOS [aapp, imft]
reduction [npop]
Systolic blood pressure [clna]
Patients [podg]
Taken [cnce]
Whole [qnco]
Correlated [qlco]
Plasma [bdsu]
renin activity [moft]
R- [spco]
P NOS [aapp, imft]
Angiotensin 2 [aapp, bacs, phsu]
R- [spco]
P NOS [aapp, imft]
chronic [tmco]
Haemodialysis [topp]
Patients [podg]
aliskiren [orch, phsu]
Blood Pressure [orgf]
Antihypertensive [phsu]
Dependent [qlco]
Basal [spco]
Levels [qlco]
Plasma [bdsu]
renin activity [moft]
Angiotensin 2 [aapp, bacs, phsu]
